Financhill
Back

Medpace Holdings Quote, Financials, Valuation and Earnings

Medpace Holdings Price Quote

$336.13
+0.39 (+-3.24%)
(Updated: September 7, 2024 at 5:00 AM ET)

Medpace Holdings Key Stats

Sell
33
Medpace Holdings (MEDP) is a Sell

Day range:
$335.51 - $352.38
52-week range:
$227.21 - $459.77
Dividend yield:
0%
P/E ratio:
37.81
P/S ratio:
5.28
P/B ratio:
13.63%

Volume:
287.8K
Avg. volume:
253.9K
1-year change:
25.35%
Market cap:
$10.4B
Revenue:
$1.9B
EPS:
$10.63

How Much Does Medpace Holdings Make?

Is Medpace Holdings Growing As A Company?

  • What Is Medpace Holdings's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.15%
  • What Is Medpace Holdings's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.42%

Medpace Holdings Stock Price Performance

  • Did Medpace Holdings Stock Go Up Last Month?
    Medpace Holdings share price went down by -11.65% last month
  • Did MEDP's Share Price Rise Over The Last Year?
    MEDP share price rose by 25.35% over the past 1 year

What Is Medpace Holdings 52-Week High & Low?

Medpace Holdings Price To Free Cash Flow

Is It Risky To Buy Medpace Holdings?

  • How Much Debt Does Medpace Holdings Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Medpace Holdings Have?
    Cash and short term investments quarterly total is $510.9M
  • What Is Medpace Holdings’s Book Value Per Share?
    Book value per share is 24.63

Is Medpace Holdings Cash Flow Positive?

  • What Is MEDP Cash Flow From Operations?
    Cash flow from operations (TTM) is $539.9M
  • What Is Medpace Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$39.4M
  • What Is Medpace Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$26.9M

Medpace Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    MEDP return on invested capital is 58.36%
  • What Is Medpace Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is 20.55%
  • What Is MEDP Return On Equity?
    ROE is a measure of profitability and is 59.49%

Medpace Holdings Earnings Date & Stock Price

Medpace Holdings Competitors

  • Who Are Medpace Holdings's Competitors?
    Below is a list of companies who compete with Medpace Holdings or are related in some way:
    • Adial Pharmaceuticals Inc (ADIL)
    • Azitra Inc (AZTR)
    • Cellectar Biosciences Inc (CLRB)
    • SeaStar Medical Holding Corp (ICU)
    • Jaguar Health Inc (JAGX)

Medpace Holdings Dividend Yield

Medpace Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 42.49% 5.24%
Revenue: 14.59% -0.07%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 406.91
Upside from Last Price: 21.2%

Major Shareholders

  • How many MEDP shares are owned by institutional investors?
    37.2M MEDP shares are owned by institutional investors
  • How many MEDP shares are owned by insiders?
    793.6K MEDP shares are owned by insiders